Lipocine
LPCN
33 hedge funds and large institutions have $5.42M invested in Lipocine in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
1,223% more call options, than puts
Call options by funds: $172K | Put options by funds: $13K
231% more capital invested
Capital invested by funds: $1.64M → $5.42M (+$3.79M)
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
18% more funds holding
Funds holding: 28 → 33 (+5)
0.08% more ownership
Funds ownership: 0.45% → 0.53% (+0.08%)
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
-$62.8K |
| 2 |
FPCG
Fort Pitt Capital Group
Pittsburgh,
Pennsylvania
|
-$25K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$9.34K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.74K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $4K | – | – | – |
|
|
BFEC
27
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $2K | – | – | – |
|
28
Morgan Stanley
New York
| $2K | – | – | – |
|
|
29
UBS Group
Zurich,
Switzerland
| $1K | -$1.74K | -134 | -69% |
|
30
Bank of America
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
MF
31
Manchester Financial
Westlake Village,
California
| $1K | – | – | – |
|
|
SFS
32
Sowell Financial Services
North Little Rock,
Arkansas
| $1K | – | – | – |
|
|
FPCG
33
Fort Pitt Capital Group
Pittsburgh,
Pennsylvania
| – | -$25K | -3,044 | Closed |
|
|
34
Citadel Advisors
Miami,
Florida
| – | -$9.34K | -721 | Closed |
|
|
PAG
35
Private Advisor Group
Morristown,
New Jersey
| – | -$5K | -588 | Closed |
|
36
Simplex Trading
Chicago,
Illinois
| – | -$78 | -6 | Closed |
|
37
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -4 | Closed |
|
LPCN Hedge Fund Activity: Q2 2020 in Review
33 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q2 2020, worth a combined $5.42M — up 231% from $1.64M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new LPCN positions and 5 closed out — a net gain of 5 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Banco Bilbao Vizcaya Argentaria, opening a new position worth an estimated $152K. The largest seller was BlackRock, cutting an estimated $62.8K.
- 33 institutional investors held Lipocine (LPCN) as of Q2 2020, up from 28 in Q1 2020.
- Funds reported $5.42M of Lipocine stock for Q2 2020, up 231% quarter-over-quarter.
- 10 funds opened new Lipocine positions in Q2 2020 and 5 closed out, a net change of +5 holders.
- The largest Lipocine buyer in Q2 2020 was Banco Bilbao Vizcaya Argentaria, an estimated $152K added.
- The largest Lipocine seller in Q2 2020 was BlackRock, an estimated $62.8K sold.
Based on aggregated 13F filings for Q2 2020.